National Bio-Founder Biotech Co., Ltd. was founded in 2009 with a registered capital of 70 Million RMB and covers a land about 55000m2 with 25700m2 building area. It is a high-tech company located in the China Medical City, the one and only medical high-tech zone in China. The company mainly engages in the R&D and manufacturing of IVD kits, bio-medicine and prophylactic vaccines as well as medical apparatus and equipment. Our R&D Center is located in USA devoted to the R&D of world leading IVD technologies. At present, we have obtained two patents of invention and two certificates of high-tech products. A large scale industrial base with an annual output of 10 million molecular diagnostic kits and 1000 sets of molecular testing instruments has been established consisting of GMP standard nucleic plant, Elisa plant, semi-work plant, collaurum plant, laboratory animal room, power center and modern office facilities (R&D center).
The company has been renowned as one of the Top 10 Middle and Small Sized Enterprises of Fast Growing in China Medical City due to its dynamic development trend in recent years.
National Bio-Founder Biotech Co., Ltd. has been devoted himself for years to the R&D of molecular diagnostic technology and has undertaken more than 10 important projects such as International Cooperative Project of State Science and Technology Ministry, the National High Technology Research and Development Program ("863"Program) of China, National Science and Technology Major Project, Major Industrial Projects of State Development and Reform Commission, Technical Innovation Project of Ministry of Industry and Information, project of Development and Reform Commission of Jiangsu Province and project for Transformation of Scientific and Technological Achievements of Jiangsu Province. Great achievements have been made by us, for example, we have applied for 5 patents of invention and among which 2 have been licensed.
HBV Pre-S1 Agent Diagnostic Kit (Elisa Method ) (Registration No.: SFDA Instrument(Approval) 3400328# of 2013) and HBcAb IgM Diagnostic Kit(Elisa Method) (Registration No.: SFDA Instrument(Approval)3400327# of 2013) have been renowned as the High-tech Products of Jiangsu Province.
As a cutting edge technology research and innovation oriented hi-tech company, we have established a new mature and stable technical platform of Nucleic Acid Detection Technology through independent development and joint development. We have developed a HPV clinical diagnostic kit which is the first one to detect the HPV virus using the isothermal technology. We have obtained the products’ registration certificates issued by SFDA such as HBV Pre-S1 Agent Diagnostic Kit (Elisa Method ), HBcAb IgM Diagnostic Kit(Elisa Method ) , 15 type of HPV and 16/18 types of HPV Nucleic Acid Detection Kit (Isothermal amplification-fluorescence method) , and HPV Genotyping Kit (Isothermal amplification-fluorescence method) . Meanwhile, we have developed the isothermal fluorescence detector as the corollary apparatus for the kits, which fills in the blank of this kind of apparatus in China. Depending on our technical platform, we are now endeavoring to expand the serialization and integration of our product lines and apparatus.
In domestic IVD industry, National Bio-Founder is one of the few companies having more than 5 patents of innovation, which creates products of multiple prices and Echelon formation. We can satisfy customers’ various demands and price affordability.
We will always adhere to our business philosophy of Motivation, Concentration, Innovation and Service. To be the best innovative product and service provider in IVD industry is our development vision. Adhering to the strategy of Capital Plus Innovation and management philosophy of Quality First and Striving for Excellence, we are willing to cooperate with all the friends from various cycles of the society to realize the mutual benefit and feed back the shareholders, customers and employees. Thus to make our contributions to the development of China medical diagnostic industry and health-care industry.